Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Samrat Pharmachem Ltd

NSE: SAMRATPH · BSE: 530125 · Pharmaceuticals & Biotechnology · 15 announcements

Share price
₹239.05
Market cap
₹73.86 Cr
Revenue (annual)
₹289.7 Cr
Net profit (annual)
₹-3.31 Cr
P/E (TTM)
-33.5×Sector 47.4×
Promoter holding
49.09%+0.00% QoQ
FII holding
3.24%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

16:15 IST BSE
Other Announcement

Samrat Pharmachem Other Announcement

Samrat Pharmachem Limited appointed M/s Divyesh J Shah & Associates as Statutory Auditors following the expiry of the previous auditor's tenure at the 34th Annual General Meeting.

15:44 IST BSE
Other Announcement

Samrat Pharmachem Other Announcement

Samrat Pharmachem appointed Divyesh J Shah & Associates as Statutory Auditors for five years. The term spans from the 34th to 39th Annual General Meeting.

Execution
5 years
14:38 IST BSE
Other Announcement

Samrat Pharmachem Other Announcement

Samrat Pharmachem Limited submitted its Annual Secretarial Compliance Report for FY 2025-26. The report by A.A. Mulla & Associates confirms general regulatory adherence with minor historical filing delays.